We have been a supporting member of the Paul-Ehrlich-Gesellschaft für Infektionstherapie e. V. (PEG) since the beginning of 2026. The Paul Ehrlich Society is an interdisciplinary scientific medical society based in Germany with members in the DACH region, which focuses on research, teaching and the application of infection therapies.
We are proud to support this important work. Find out more about the work of the association on the PEG website.
PAION Pharma launched Byfavo® with the active ingredient remimazolam in Germany on January 1, 2026. New active ingredients are a
Since January 1, 2026, PAION Pharma has been a cooperating member of the German Society for Internal Intensive Care and
You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information